Fundz

Hikma Ventures Participates in CAD4.0 million Series A Financing Round for SeamlessMD to Expand Digital Patient Engagement Leadership

PRIVATEAug 26, 2020
OhioManufacturingBiotechnologyHealth CarePharmaceutical

Description

 Hikma Pharmaceuticals PLC (Hikma) announces that its venture capital arm, Hikma Ventures has participated in a CAD4.0 million Series A round of financing for SeamlessMD. The round was led by MEDTEQ, bringing the company's total funding to CAD7.4 million. Anges Québec, AIoT Health, and health IT entrepreneur Sanjay Malaviya also participated in the oversubscribed round.

Quick answer

Hikma Pharmaceuticals raised an undisclosed amount in a funding round, dated August 26, 2020. Hikma Pharmaceuticals is based in Ohio, United States.

How much did Hikma Pharmaceuticals raise?
Hikma Pharmaceuticals raised an undisclosed amount in a funding round on August 26, 2020.
What does Hikma Pharmaceuticals do?
Hikma Pharmaceuticals is a leading player in the U.S. generic drug market.
Where is Hikma Pharmaceuticals based and how big is it?
Hikma Pharmaceuticals is based in Ohio, United States.
Who are the decision-makers at Hikma Pharmaceuticals?
Fundz holds 3 contacts at Hikma Pharmaceuticals, including the Vice President. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and Manufacturing around the same time

Companies in the same sectors as Hikma Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • Helus Pharma raised an undisclosed amount on September 1, 2020.
  • valisure llc raised $3.8M (Seed) on July 14, 2020.
  • Oragenics raised an undisclosed amount (Funding Round) on September 28, 2020.
  • Medcura raised $22M on September 28, 2020.
  • Azora Therapeutics, Inc. (DE) raised $500K on September 25, 2020.
  • LAVA Therapeutics raised $83M (Series C) on September 17, 2020.

Who to call at Hikma Pharmaceuticals, and when

A new round usually means Hikma Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Hikma Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Hikma Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Hikma Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Hikma Pharmaceuticals

Location

Ohio, United States

About

Hikma Pharmaceuticals is a leading player in the U.S. generic drug market. The company specializes in the manufacturing of complex generics, particularly sterile injectables, aimed at addressing the growing demand for oncology and chronic-care drugs. With a significant expansion in Ohio, Hikma aims to solidify its position by leveraging AI-driven private markets for funding. The company is focused on producing over 12 billion doses annually by 2030.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Hikma Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsHana R., Vice President hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Hikma Pharmaceuticals's next move

See what Strategic adds

Hikma Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.